Global Medical REIT, Inc. (NASDAQ:GMRE) – Equities researchers at B. Riley raised their FY2017 earnings per share (EPS) estimates for Global Medical REIT in a research note issued to investors on Friday. B. Riley analyst B. Maher now forecasts that the company will earn $0.33 per share for the year, up from their previous forecast of $0.27. B. Riley has a “Buy” rating and a $10.50 price target on the stock. B. Riley also issued estimates for Global Medical REIT’s Q4 2017 earnings at $0.12 EPS, Q1 2018 earnings at $0.15 EPS, Q2 2018 earnings at $0.19 EPS, Q3 2018 earnings at $0.24 EPS, FY2018 earnings at $0.83 EPS, Q1 2019 earnings at $0.25 EPS, Q2 2019 earnings at $0.25 EPS and FY2019 earnings at $1.01 EPS.

Global Medical REIT (NASDAQ:GMRE) last posted its earnings results on Thursday, August 10th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.17). The company had revenue of $7.42 million during the quarter, compared to the consensus estimate of $6.16 million. Global Medical REIT had a negative return on equity of 1.53% and a negative net margin of 8.39%.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/brokers-set-expectations-for-global-medical-reit-inc-s-fy2017-earnings-gmre/1699131.html.

Several other research firms also recently issued reports on GMRE. Zacks Investment Research downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Tuesday, November 7th. FBR & Co reaffirmed a “buy” rating and issued a $10.50 price objective (up previously from $10.00) on shares of Global Medical REIT in a research note on Monday, September 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of Global Medical REIT in a research note on Friday, September 1st. Finally, DA Davidson downgraded Global Medical REIT from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $11.00 to $10.00 in a research note on Tuesday, August 22nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $10.60.

Global Medical REIT (NASDAQ GMRE) opened at $9.28 on Monday. Global Medical REIT has a fifty-two week low of $7.04 and a fifty-two week high of $10.25.

Several institutional investors have recently added to or reduced their stakes in the company. Wedbush Securities Inc. increased its stake in shares of Global Medical REIT by 5.8% in the second quarter. Wedbush Securities Inc. now owns 15,334 shares of the company’s stock valued at $137,000 after buying an additional 834 shares during the period. Bank of New York Mellon Corp increased its position in Global Medical REIT by 0.7% during the 1st quarter. Bank of New York Mellon Corp now owns 126,355 shares of the company’s stock valued at $1,147,000 after purchasing an additional 937 shares during the period. Teachers Advisors LLC increased its position in Global Medical REIT by 5.0% during the 2nd quarter. Teachers Advisors LLC now owns 26,279 shares of the company’s stock valued at $235,000 after purchasing an additional 1,243 shares during the period. UBS Group AG increased its position in Global Medical REIT by 14.2% during the 1st quarter. UBS Group AG now owns 11,847 shares of the company’s stock valued at $108,000 after purchasing an additional 1,477 shares during the period. Finally, Northern Trust Corp increased its position in Global Medical REIT by 2.0% during the 2nd quarter. Northern Trust Corp now owns 147,978 shares of the company’s stock valued at $1,323,000 after purchasing an additional 2,873 shares during the period.

About Global Medical REIT

Earnings History and Estimates for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.